Search clinical trials for: Ebselen
Total 34 results
-
University of OxfordMedical Research Council; Sound Pharmaceuticals, IncorporatedRecruitingDepressive Disorder, Treatment-ResistantUnited Kingdom
-
University of OxfordStanley Medical Research Institute; Sound Pharmaceuticals, IncorporatedCompletedBipolar Disorder | Bipolar Disorder, ManicUnited Kingdom
-
Sound Pharmaceuticals, IncorporatedVA Puget Sound Health Care SystemUnknownHead and Neck Cancer | Lung Cancer | Hearing Loss | Ototoxicity | Tinnitus | NeuropathyUnited States
-
Sound Pharmaceuticals, IncorporatedMedical University of South Carolina; Cystic Fibrosis FoundationEnrolling by invitation
-
Sound Pharmaceuticals, IncorporatedUniversity of FloridaCompletedTemporary Auditory Threshold ShiftUnited States
-
Sound Pharmaceuticals, IncorporatedCompleted
-
Sound Pharmaceuticals, IncorporatedCompleted
-
Sound Pharmaceuticals, IncorporatedCompleted
-
Seoul National University HospitalTerminatedCarcinoma, Papillary, FollicularKorea, Republic of
-
Seoul National University HospitalRecruitingThyroidectomy | Laryngeal Nerve Injuries | Voice ChangeKorea, Republic of
-
GlaxoSmithKlineCompletedPostoperative Nausea and Vomiting | Nausea and Vomiting, PostoperativeUnited States, Australia, Poland, Belgium, Canada, Netherlands, Finland, South Africa, Chile, United Kingdom, Czech Republic, Turkey
-
Rigshospitalet, DenmarkOdense University Hospital; Hvidovre University Hospital; Bispebjerg Hospital; Herlev... and other collaboratorsUnknownGraves' HyperthyroidismDenmark
-
Oslo University HospitalPharma NordCompletedStatin TherapyNorway
-
Brigham and Women's HospitalCompletedType 2 Diabetes Mellitus | Type 1 Diabetes MellitusUnited States
-
BayerCompleted
-
BayerCompletedOveractive BladderSouth Africa
-
Warner ChilcottTerminatedNeurogenic Detrusor OveractivityUnited States, Colombia
-
Sound Pharmaceuticals, IncorporatedMed-El CorporationNot yet recruitingHearing Loss | Cochlear Trauma
-
Sound Pharmaceuticals, IncorporatedActive, not recruiting
-
Sound Pharmaceuticals, IncorporatedEnrolling by invitationCoronavirus Infection | Covid19 | Corona Virus Infection | CoronavirusUnited States
-
Universidad de ValparaisoRecalcine (GynoPharm)CompletedOveractive BladderChile
-
Sound Pharmaceuticals, IncorporatedEnrolling by invitationCoronavirus Infection | Covid19 | Corona Virus Infection | CoronavirusUnited States
-
Sound Pharmaceuticals, IncorporatedUnknownNoise Induced Hearing LossUnited States
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Stage III Breast Cancer AJCC v7 | Stage IIIA Breast Cancer AJCC v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7United States
-
Northwestern UniversityNational Cancer Institute (NCI); BHR Pharma, LLCRecruitingEstrogen Receptor Positive | Ductal Breast Carcinoma In SituUnited States
-
National Cancer Institute (NCI)CompletedStage IV Breast Cancer | Recurrent Breast Carcinoma | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Positive | Progesterone Receptor Positive | Male Breast CarcinomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingBreast Ductal Carcinoma In Situ | Invasive Breast Carcinoma | Multicentric Breast Carcinoma | Multifocal Breast Carcinoma | Synchronous Bilateral Breast CarcinomaUnited States, France, Spain, Canada, Saudi Arabia, Puerto Rico, Korea, Republic of, Ireland, Colombia, Mexico
-
National Cancer Institute (NCI)NCIC Clinical Trials Group; Cancer and Leukemia Group B; North Central Cancer... and other collaboratorsActive, not recruitingHormone Receptor Positive | Stage IA Breast Cancer AJCC v7 | Stage IB Breast Cancer AJCC v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Stage IIIB Breast Cancer AJCC v7 | Breast AdenocarcinomaUnited States, Canada, Australia, Puerto Rico, New Zealand, Ireland, Peru, United Kingdom
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)WithdrawnStage 0 Breast Cancer | Invasive Breast Carcinoma | Stage IA Breast Cancer | HER2/Neu Negative | PostmenopausalUnited States
-
ETOP IBCSG Partners FoundationNational Cancer Institute (NCI); NCIC Clinical Trials Group; Cancer and Leukemia... and other collaboratorsActive, not recruitingRecurrent Breast Carcinoma | Stage IIIA Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Estrogen Receptor Positive Breast Cancer | Progesterone Receptor Positive TumorUnited States, Canada, Switzerland
-
National Cancer Institute (NCI)NRG OncologyCompletedRecurrent Uterine Corpus Carcinoma | Endometrial Carcinoma | Stage IIIA Uterine Corpus Cancer | Stage IIIB Uterine Corpus Cancer | Stage IVA Uterine Corpus Cancer | Stage IVB Uterine Corpus Cancer | Stage IIIC1 Uterine Corpus Cancer | Stage IIIC2 Uterine Corpus CancerUnited States
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingOvarian Serous Adenocarcinoma | Primary Peritoneal Serous Adenocarcinoma | Recurrent Ovarian Low Grade Serous Adenocarcinoma | Borderline Ovarian Serous Tumor | Micropapillary Serous Carcinoma | Recurrent Primary Peritoneal Serous AdenocarcinomaUnited States, United Kingdom
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Breast Carcinoma | Invasive Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Stage III Breast Cancer AJCC v6United States, Puerto Rico
-
National Cancer Institute (NCI)Eastern Cooperative Oncology Group; Canadian Cancer Trials Group; Southwest Oncology... and other collaboratorsCompletedHER2 Positive Breast Carcinoma | Stage IA Breast Cancer AJCC v7 | Stage IB Breast Cancer AJCC v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Stage IIIA Breast Cancer AJCC v7 | Breast AdenocarcinomaUnited States, Canada, Peru, South Africa